Edition:
United States

Boiron SA (BOIR.PA)

BOIR.PA on Paris Stock Exchange

80.22EUR
18 Aug 2017
Change (% chg)

€0.05 (+0.06%)
Prev Close
€80.17
Open
€80.17
Day's High
€80.50
Day's Low
€80.01
Volume
2,237
Avg. Vol
5,407
52-wk High
€92.91
52-wk Low
€73.02

BOIR.PA

Chart for BOIR.PA

About

Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy... (more)

Overall

Beta: 0.95
Market Cap(Mil.): €1,557.45
Shares Outstanding(Mil.): 19.41
Dividend: 1.60
Yield (%): 1.99

Financials

  BOIR.PA Industry Sector
P/E (TTM): 19.02 31.45 32.56
EPS (TTM): 4.22 -- --
ROI: 13.64 15.33 14.89
ROE: 17.56 16.35 16.13

BRIEF-Boiron says Canadian Supreme Court allows class action to proceed

* SAID ON THURSDAY THE SUPREME COURT IN CANADA REJECTED THE APPEAL OF OUR CANADIAN SUBSIDIARY AGAINST THE JUDGMENT DATED OCTOBER 26, 2016 OF THE QUEBEC COURT OF APPEAL

May 19 2017

BRIEF-Boiron Q1 revenue up at 160.3 mln euros

* Q1 revenue 160.3 million euros ($172.1 million) versus 154.1 million euros year ago

Apr 20 2017

BRIEF-Boiron FY net income group share rises to 77.7 million euros

* FY revenue 614.5 million euros ($653.52 million) versus 607.8 million euros year ago

Mar 15 2017

Earnings vs. Estimates